XML 406 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated statement of changes in equity (Parenthetical)
€ in Millions, £ in Millions
12 Months Ended
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Jul. 07, 2022
EUR (€)
Share capital reduction [1]     € 0  
Hyperinflation adjustment € 308 € 514 280  
Other movements in equity (2) (136) [2] 154 [3]  
Non-controlling interest in acquiree 20      
Share premium account        
Share capital reduction [1]     20,626  
Other movements in equity [3]     (2)  
Other reserves        
Other movements in equity € 2 € (258) [2] (82) [3]  
Welly Health        
Other movements in equity     € 82  
Nutrafol        
Non-controlling interest in acquiree       € 99
Nutrafol | Other reserves        
Non-controlling interest purchase option       € (269)
[1]
(a)Share premium has been adjusted to reflect the legal share capital of the PLC company, which reduced by £18,400 million following court approval on 15 June 2021.
[2] Includes the following items related to the acquisition of Nutrafol: €(269) million non-controlling interest purchase option in other reserves and €99 million non-controlling interest recognised on acquisition.
[3] Includes a hyperinflation adjustment of €280 million and €82 million related to the Welly acquisition.